← Every applicant
Xgen Pharms FDA Approvals
3 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ERIBULIN MESYLATENew drugMar 16, 2026SOLUTION, INTRAVENOUS |
| DEHYDRATED ALCOHOLNew drugJun 23, 2025SOLUTION, INTRA-ARTERIAL |
| CYCLOPHOSPHAMIDENew drugOct 18, 2022INJECTABLE, INJECTION |